Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Taysha Gene Therapies, Inc. - Common Stock
(NQ:
TSHA
)
4.400
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Taysha Gene Therapies, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
↗
August 14, 2023
Via
Benzinga
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
August 14, 2023
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...
Via
Benzinga
Why Taysha Gene Therapies Stock Is Surging
↗
August 14, 2023
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) shares are surging higher Monday.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Taysha Gene Therapies
↗
June 30, 2023
Via
Benzinga
Analyst Ratings for Taysha Gene Therapies
↗
May 12, 2023
Via
Benzinga
US Stocks Turn Higher; BioXcel Therapeutics Shares Plummet
↗
August 14, 2023
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 80 points on Monday. The Dow traded up 0.01% to 35,284.34 while the NASDAQ rose 0.64% to 13,732.05....
Via
Benzinga
Topics
Stocks
Dow Falls 50 Points; Monday.com Posts Upbeat Results
↗
August 14, 2023
U.S. stocks traded mostly lower this morning, with the Dow Jones falling around 50 points on Monday. Following the market opening Monday, The Dow traded down 0.14% to 35,230.38 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 14, 2023
Via
Benzinga
Taysha Gene Therapies Touts Encouraging Preclinical Data From Rett Syndrome Candidate
↗
May 19, 2023
Taysha Gene Therapies Inc (NASDAQ: TSHA) presented preclinical data from neonatal mouse models on TSHA-102 for Rett syndrome, including new data in wild-type mice, at the American Society of Gene and...
Via
Benzinga
Recap: Taysha Gene Therapies Q1 Earnings
↗
May 11, 2023
Via
Benzinga
Earnings Preview: Taysha Gene Therapies
↗
May 10, 2023
Via
Benzinga
12 Analysts Have This to Say About Taysha Gene Therapies
↗
March 29, 2023
Via
Benzinga
Taysha Gene Therapies's Earnings: A Preview
↗
March 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
March 15, 2023
On Wednesday, 479 stocks made new 52-week lows.
Via
Benzinga
FDA's Approval For Sarepta's Duchenne Gene Therapy, A Boost for Taysha Gene's Rare Neuropathy Treatment: Analyst Weighs
↗
May 15, 2023
On Friday, the FDA's adcomm voted 8 to 6 in support of accelerated approval of Sarepta Therapeutics Inc's SRPT SRP-9001 (delandistrogene moxeparvovec) for ambulatory patients with
Via
Benzinga
Earnings Scheduled For May 11, 2023
↗
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
March 29, 2023
On Wednesday, 81 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
March 16, 2023
Thursday's session saw 337 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
February 24, 2023
On Friday, 135 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
March 24, 2023
On Friday, 469 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
February 15, 2023
On Wednesday, 35 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
February 10, 2023
During Friday, 48 stocks hit new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2023
↗
February 02, 2023
Via
Benzinga
US Stocks Turn Higher After Fed Raises Key Overnight Interest Rate; Nasdaq Up 1.5%
↗
February 01, 2023
U.S. stocks turned higher toward the end of trading, following the release of interest rate decision. The Dow traded up 0.05% to 34,104.56 while the NASDAQ rose 1.58% to 11,767.44. The S&P 500 also...
Via
Benzinga
Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
February 01, 2023
Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
February 01, 2023
Via
Benzinga
Dow Dips 300 Points; Snap Shares Plunge
↗
February 01, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
↗
February 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 01, 2023
Via
Benzinga
Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket
↗
February 01, 2023
Gainers
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
